|
|
|
Vol. 14, No. 9, pp. 1085-1097, May 1, 2000
Departments of 1 Cell Biology, 2 Developmental and Molecular Biology, and 4 Molecular Genetics, Albert Einstein College of Medicine, The Bronx, New York 10461 USA; 3 Ludwig Institute for Cancer Research, LaJolla, California 92093 USA
| |
ABSTRACT |
|---|
|
|
|---|
Msh4 (MutS homolog 4) is a member of the mammalian mismatch repair gene family whose members are involved in postreplicative DNA mismatch repair as well as in the control of meiotic recombination. In this report we show that MSH4 has an essential role in the control of male and female meiosis. We demonstrate that MSH4 is present in the nuclei of spermatocytes early in prophase I and that it forms discrete foci along meiotic chromosomes during the zygotene and pachytene stages of meiosis. Disruption of the Msh4 gene in mice results in male and female sterility due to meiotic failure. Although meiosis is initiated in Msh4 mutant male and female mice, as indicated by the chromosomal localization of RAD51 and COR1 during leptonema/zygonema, the chromosomes fail to undergo normal pairing. Our results show that MSH4 localization on chromosomes during the early stages of meiosis is essential for normal chromosome synapsis in prophase I and that it acts in the same pathway as MSH5.
[Key Words: Mismatch repair; meiosis; chromosome synapsis; recombination; germ cell]
| |
Introduction |
|---|
|
|
|---|
The DNA mismatch repair system (MMR) in
eukaryotic cells is responsible for the repair of DNA mismatches that
can result from a number of different mechanisms including DNA
replication, genetic recombination, and chemical modification of DNA or
nucleotide pools. Studies in yeast, and more recently in mice, have
also revealed a role for MMR proteins in the control of meiotic
recombination. The bacterial DNA mismatch repair system typified by the
Escherichia coli Mut HLS system is the simplest and best
understood. This system is capable of repairing both single nucleotide
mismatches as well as small insertion/deletion mismatches
(for reviews, see Kolodner 1996
; Modrich and Lahue 1996
). In E. coli, the MutS protein recognizes and binds to mismatched
nucleotides. In a subsequent step a second protein, MutL, interacts
with MutS and activates a third protein, MutH, which is an
endonuclease. MutH nicks the unmethylated strand of hemimethylated DNA
in the vicinity of a mismatch, thereby directing the repair of the
newly synthesized strand.
Although the essential components of this MMR system have been
conserved in eukaryotes, the repair system is more complex than in
E. coli and involves several MutS and MutL homologs. In yeast
Saccharomyces cerevisiae there are six homologs of the
DNA-binding protein MutS designated MutS homolog (MSH) 1-6. There are
also four known homologs of the MutL gene in yeast, designated MLH1, MLH2, PMS1, and MLH3 (for review, see Kolodner 1996
; Crouse 1998
). The
mammalian genome has homologs for all of these genes except MSH1,
which, if present, is yet to be discovered (Buermeyer et al. 1999
;
Kolodner and Marsischky 1999
).
It is well established that in eukaryotes the products of the MSH2,
MSH3, MSH6, as well as MLH1, PMS1, and MLH3 genes are involved in DNA
mismatch repair. In eukaryotes, MMR requires a complex of MSH2-MSH6
for the repair of single base mispairs and either a complex of
MSH2-MSH6 or MSH2-MSH3 for the repair of
insertion/deletion mispairs (Acharya et al. 1996
;
Marsischky et al. 1996
; Genschel et al. 1998
; Guerrette et al. 1998
;
Umar et al. 1998
). The two MSH complexes interact with the complexes of
MLH1-PMS1 (PMS2 in human) or MLH1-MLH3 for the repair of the
different mismatches (Prolla et al. 1994
; Li and Modrich 1995
; Habraken
et al. 1997
; Pang et al. 1997
; Flores-Rozas and Kolodner 1998
; Wang et
al. 1999
).
Germ-line mutations in some of the MMR genes in humans are associated
with the cancer predisposition syndrome, hereditary nonpolyposis colon
cancer (HNPCC). This syndrome is inherited in an autosomal dominant
fashion and is characterized by a predispostion to develop colonic and
extracolonic tumors where the tumors have a characteristic replication
error (RER+) phenotype (Kinzler and Vogelstein 1996
). Germ-line
mutations in MSH2 and MLH1 account for a majority of HNPCC families
(Peltomaki and Vasen 1997
). Recently, it is was found that MSH6
germ-line mutations account for a small number of HNPCC families but
appear to be also responsible for a larger number of late-onset
familial colorectal cancer cases (Kolodner et al. 1999
; Wu et al. 1999
).
Studies in bacteria and yeast showed that the MMR system is also
involved in the control of recombination. For example, genetic analysis
in yeast showed that the complexes consisting of the MMR proteins
MSH2-MSH6, MSH2-MSH3, and MLH1-PMS1 function in the prevention of
recombination between divergent DNA sequences. This role in
recombination is dependent on interactions with other proteins
including RAD1-RAD10 and EXO1 (Nakagawa et al. 1999
). Two other
members of the yeast MSH family, MSH4 and MSH5, play a role
specifically in meiotic recombination. Yeast strains carrying null
mutations in either MSH4 or MSH5 show reduced rates of crossing over
but not gene conversion, increased chromosomal nondisjunction, and
reduced spore viability (Ross-Macdonald and Roeder 1994
;
Hollingsworth et al. 1995
). The analysis of MSH4-MSH5 double
mutant yeast strains indicates that MSH4 and MSH5 function in the same
genetic pathway with MSH5 being epistatic to MSH4 (Hollingsworth et al.
1995
). Yeast MSH4 and MSH5 are able to form heterodimeric complexes
similar to the mitotic MSH proteins (Pochart et al. 1997
). In a manner analogous to mitotic MMR, the analysis of MSH4-MLH1 double mutant yeast strains indicated that the meiosis-specific MutS homologs require
the function of MLH1 for the promotion of meiotic crossing over (Hunter
and Borts 1997
).
To understand the role of the mammalian mismatch repair genes in DNA
repair, cancer predisposition and meiosis, several mouse lines with
targeted mutations in MMR genes have been generated. Mice that carry
mutations in the mismatch repair genes Msh2 (de Wind et al.
1995
; Reitmair et al. 1995
), Msh3 (de Wind et al. 1999
;
Edelmann et al. 2000
), Msh6 (Edelmann et al. 1997
),
Mlh1 (Baker et al. 1996
; Edelmann et al. 1996
), Pms2
(Baker et al. 1995
), and Pms1 (Prolla et al. 1998
) have been
described. Msh2
/
, Mlh1
/
,
Msh6
/
, and Pms2
/
mice
display a predisposition to tumors, although the degree of this predisposition
and the latency for tumor development differ. Mice lacking
Msh3 and Pms1 are reported to be normal.
Mice that are homozygous for mutations in the somatic members of the
MSH gene family (Msh2, Msh3, and Msh6), are
viable and fully fertile (de Wind et al. 1995
; Reitmair et al. 1995
;
Edelmann et al. 1997
, 2000
). However, mice that are mutant for the MutL homologs Pms2 and Mlh1 also exhibit a meiotic defect
in addition to their cancer predisposition phenotypes. Male mice
bearing a homozygous mutation in Pms2 show abnormal chromosome
pairing during meiosis and are sterile whereas the females are fertile
(Baker et al. 1995
). Mice with mutations in the Mlh1 gene are
viable but both sexes are sterile. Normal chromosome pairing was
observed in pachynema of prophase I in spermatocytes from Mlh1
mutant males, but most of the cells fail to progress beyond pachynema
(Baker et al. 1996
; Edelmann et al. 1996
).
The observation that mutations in the MutL homologous genes result in a
different meiotic phenotype compared to mutations in the MutS
homologous genes with which they interact during mitotic DNA mismatch
repair indicates that the MLH proteins employ different members of the
MSH family as partners during meiosis. Recently, the human homologs of
the yeast MSH4 and MSH5 genes have been isolated and their expression
in human germ cells (Paquis-Flucklinger et al. 1997
; Her and Doggett
1998
; Winand et al. 1998
) suggests that one or both of these gene
products may be partners for MLH1 during meiosis. Indeed, Msh5
mutant mice are viable, but both males and females are sterile. Meiosis
in these mice cannot progress normally because chromosome pairing is severely
affected during prophase I (de Vries et al. 1999
; Edelmann et al. 1999
).
To study the meiotic function of mammalian MSH4 we analyzed its expression during the different stages of meiosis I. We also assessed the role of MSH4 in meiosis by generating mice that carry a null mutation in this gene. Our results show that MSH4 is required for normal chromosome pairing during prophase I. The combination of the Msh4 mutation with a mutation in Msh5 further showed that MSH4 and MSH5 are both essential for proper chromosome pairing during mammalian meiosis and that they act in the same pathway.
| |
Results |
|---|
|
|
|---|
Association of MSH4 with meiotic chromosomes
To determine the tissue-specific expression pattern of Msh4
Northern blot analysis was performed using a cDNA probe spanning the
entire coding region of the human MSH4 gene
(Paquis-Flucklinger et al. 1997
). A 3.2-kb mRNA transcript was detected
in testis but was virtually absent in all other tissues tested
including skin, lung, liver, thymus, spleen, brain, heart, kidney,
stomach, small intestine, and skeletal muscle (data not shown). The
testis-specific expression of Msh4 suggested a role similar to
its yeast counterpart in the control of meiotic processes. To further
investigate this possibility, the distribution of MSH4 protein along
meiotic chromosomes was analyzed by immunofluorescent methods. The MSH4
protein colocalized with the synaptonemal complex (SC) and axial
element protein COR1 on chromosome spreads prepared from wild-type
testes at day 17 postpartum (pp). MSH4 foci were found to be
colocalized with the SC from leptonema up until pachynema (Fig.
1). At leptonema, MSH4 was localized throughout the
nuclear region, although not intimately associated with the axial
element backbone of unsynapsed chromosomes (Fig. 1A,E). By zygonema,
MSH4 staining was associated directly with the axial elements
themselves, being distributed along much of the length of the meiotic
chromosomes. The foci at this stage were of variable size but were
still quantifiable (142 ± 24.7 per nucleus; Fig. 1B,E). Early in
pachynema, MSH4 was still present in discrete foci along the SC of
synapsed chromosomes, with the number of foci per bivalent remaining
high (90 ± 4.5 per nucleus; Fig. 1C,E). By midpachynema the number
of MSH4 foci declined further, with an average of 47 ± 4.5 foci
per nucleus (Fig. 1D,E).
|
Generation of Msh4 mutant mice
The localization of MSH4 on meiotic chromosomes supported a role for
this protein in meiosis. To determine the importance of MSH4 for
mammalian meiosis we generated a mouse line that carries an
inactivating mutation in the germ line. The gene targeting vector
pMsh4ex4 was designed to introduce a PGK hygromycin resistance cassette into exon 4 corresponding to codon 252 of the human MSH4 cDNA
(Fig. 2A). This modification introduces multiple stop
codons into the Msh4 reading frame as verified by sequencing
and is predicted to result in an inactivating mutation. A truncated
protein, if produced by the modified Msh4 locus, would lack
the nucleotide-binding domain and the helix-loop-helix domain located
at the COOH-end that are essential for the function of the MutS family
of proteins (Ross-Macdonald and Roeder 1994
; Paquis-Flucklinger et al.
1997
). The targeting vector pMsh4ex4 was linearized and
electroporated into embryonic stem (ES) cells. One hundred ninety-six
hygromycin-resistant clones were isolated and screened for the
homologous recombination event by PCR (Fig. 2A). Forty-three (22%) of
the analyzed clones tested positive for the correct targeting event.
The appropriate modification was verified by Southern blot analysis
(Fig. 2B). Three independently derived Msh4 ES clones were
injected into C57/Bl6 blastocysts. Chimeric animals from
all three cell lines transmitted the disrupted allele through the germ
line. Heterozygous F1 animals were interbred to obtain
homozygous mutant mice. We obtained 518 F2 offspring animals
from 11 mating pairs. Genotyping of the F2 mice revealed that
139 animals were wild type, 263 animals were heterozygous, and 116 animals were homozygous for the mutant allele. This result is
consistent with a normal Mendelian pattern of inheritance and indicates
that MSH4 is not essential for normal development.
|
Lack of Msh4 transcripts or MSH4 protein in testis of
Msh4
/
mice
Two lines of evidence indicated that the insertion of the PGK
hygromycin cassette into exon 4 resulted in an inactivating mutation.
First, to confirm that Msh4
/
mice did not produce normal transcripts we subjected testis poly(A) RNA
to Northern blot analysis (Fig. 2C). The RNA from wild-type mice
contained a 3.2-kb transcript that was also present at reduced level in
heterozygous mice. No Msh4 transcript was detectable in the
testis RNA of homozygous mutant mice. Second, the inactivation of MSH4
in homozygous mutant mice was further confirmed by immunolocalization experiments. Although MSH4 foci are readily detectable in maximal numbers on wild-type spermatocyte chromosomes at zygonema, no MSH4
protein was present on or around the meiotic chromosomes of
Msh4
/
mice at the comparable
stage of meiosis (Fig. 2D).
Fertility of Msh4
/
male mice
Msh4 mutant animals up to 12 months of age appeared to
develop normally without any discernable disease phenotype. However, whereas Msh4+/+ and
Msh4+/
males were fertile, matings
between Msh4
/
males and
wild-type females did not produce any offspring.
Msh4
/
males exhibited normal
sexual behavior and aggression, but were infertile. The testis weights
of Msh4
/
adult males was only
~50% of wild type and closer analysis revealed no spermatozoa
within the epididymides of
Msh4
/
adult males (data not
shown) or within the seminiferous tubular lumen of their testes (Fig.
3B,D). In contrast,
Msh4+/+ adult male littermates had
normal numbers of epididymal spermatozoa and numerous spermatozoa
within the seminiferous tubules, as identified by the sperm tails
protruding into the tubular lumen (Fig. 3A,C, arrowheads). To
investigate the progression of the first meiotic wave in
Msh4+/+ and
Msh4
/
males, the appearance
and progression of germ cells through meiosis was assessed
morphologically at day 23 pp, representing the time when the first
meiosis I is completed. The seminiferous tubules of
Msh4+/+ males contained an abundance
of meiotic germ cells, ranging from early spermatogonia, flattened
against the basement membrane of the tubule, to spermatocytes entering
and progressing through prophase I (Fig. 3E). These meiosis I cells
were readily identified by their enlarged size, their gradual loss of
the signal for GCNA1, a germ cell-specific marker during mitosis and
meiosis whose loss is indicative of progression to pachynema (Enders
and May 1994
), and their position further toward the lumen of the
seminiferous tubules (Fig. 3E). Some differentiating spermatids were
also apparent within tubules of
Msh4+/+ males, indicating the
completion of meiosis II in these cells (Fig. 3E). In contrast, even
during the first wave of meiosis between day 13 and 26 pp, seminiferous
tubules of Msh4
/
males
exhibited a severe depletion of spermatocytes, but not of primary
spermatogonia (Fig. 3F). Cells further in toward the lumen of the
seminiferous tubules were densely stained with GCNA1 and remained small
compared to those cells seen within the tubules of wild-type males. No
luminal cells appeared to be at meiotic stages beyond zygonema. In
addition, many cells appeared to be apoptotic as assessed by routine
morphological criteria (Fig. 3B). Thus, by adulthood, seminiferous
tubules of Msh4+/+ males contained a
cellular profile representative of all stages of the spermatogenic wave
(Fig. 3A), whereas the tubules of
Msh4
/
males were devoid of
many spermatogenic cells, having lost most of the resident type A and B
spermatogonia and all of the spermocytes (Fig. 3B). Many seminiferous
tubules of adult Msh4
/
males
contained only a single layer of spermatogonia and Sertoli cells (Fig.
3B). Interestingly, the interstitial areas of the testes of
Msh4
/
males appeared to contain many more Leydig
cells (LC, Fig. 3B,D) than those of wild-type males (Fig. 3A,C).
|
Chromosome pairing analysis in male germ cells
Analysis of meiotic chromosomes in
Msh4
/
males revealed severe
abnormalities in pairing at the zygotene stage of prophase I, with most
chromosomes failing to undergo any degree of pairing or synapsis.
However, most of the nuclei showed at least some signs of chromosomal
interactions. At day 23 pp, when most (>90%) spermatocyte nuclei
from wild-type males contained bivalent chromosomes in late zygonema or
pachynema (Fig. 4A; Table 1), <70% of spermatocyte nuclei from
Msh4
/
males contained any
paired chromosomes (Fig. 4B,C,D; Table
1). Of the
Msh4
/
cells that did show
chromosome pairing, between 2 to 3 (mean = 2.74 ± 0.23)
chromosomes per cell showed some degree of pairing. However, most
pairing was between nonhomologous chromosomes as revealed by
interactions between chromosomes of different lengths (Fig. 4C,D,
arrows). The small degree of homologous pairing that does occur is
limited and rarely apparent across the entire length of the chromosomes
(Fig. 4C,D, arrowheads). Occasionally, homologous pairing was evident
at one or both ends of a chromosome (Fig. 4D, arrows), whereas some
chromosomes were paired intermittently along their entire length (Fig.
4D, arrowhead). Chromosomes from Msh4
/
males were never
condensed, whereas pairing in wild-type spermatocytes was always
accompanied by chromosome condensation. The degree of chromosomal
interactions in Msh4
/
spermatocytes was significantly more advanced than that seen in
spermatocytes taken from either Msh5
/
or
Msh4
/
/Msh5
/
males (Fig. 4E,F; Edelmann et al. 1999
), but remained significantly disrupted when compared to wild-type littermates (Table 1).
|
|
The association of the RecA homolog RAD51 on unpaired chromosomes at
leptonema and zygonema, and loss of such association upon homologous
pairing, is now well established (Rockmill et al. 1995
; Barlow et al.
1998
). To assess the localization of this recombination protein on
meiotic chromosomes in the absence of MSH4, we performed
coimmunofluorescence using rabbit anti-mouse RAD51 and a mouse
monoclonal antibody raised against the synaptonemal complex protein
COR1. As expected, RAD51 foci were readily detectable on chromosomes
from wild-type spermatocytes at zygonema (Fig. 4G), but were lost as
pairing proceeded (Fig. 4G, arrow) and completely absent by pachynema,
a time when synapsis is complete. In contrast, the failure of
chromosomal pairing in spermatocytes from
Msh4
/
males was associated with increased
localization of RAD51 foci on the meiotic chromosomes (Fig. 4H).
Analysis of female meiosis and ovarian development in
Msh4
/
females
Meiosis I occurs synchronously in female oogonia from embryonic day
(E) 16 until birth in mice, after which time the oocytes enter a period
of dictyate arrest just after pachynema. To analyze the progression of
this first stage of meiosis I, ovaries from Msh4+/+ and
Msh4
/
females were removed
during the neonatal period (E18 through to day 4 pp). Staining of germ
cells with an antibody against GCNA1 revealed a steady loss of germ
cells in Msh4
/
females soon
after birth (Fig. 5A-F). At E18, the number of
GCNA1-positive cells in Msh4+/+ and
Msh4
/
ovaries was similar
(Fig. 5A,B). By day 2 pp, the earliest signs of follicular development
as part of ovarian reorganization were apparent in Msh4+/+
ovaries (Fig. 5C, arrows), whereas many of the oogonia in
Msh4
/
cells had already been
lost (Fig. 5D). By day 4 pp, when all of the remaining oocytes in
Msh4+/+ ovaries were enclosed by
readily identifiable primordial follicles (Fig. 5E, arrows), the vast
majority of oocytes in Msh4
/
ovaries had been lost (Fig. 5F), indicating a loss of oocytes before
dictyate arrest in the Msh4
/
females.
|
To assess the consequences of oocyte loss in
Msh4
/
females, ovaries were
taken at 4, 16, and 28 weeks of life. In contrast to the oocyte-rich
ovary in 4-week-old Msh4+/+ females
(Fig. 5G), Msh4
/
females had
very small ovaries containing few if any oocytes at this age (Fig. 5H).
Often, many divergent morphologies were present within the same
female, as is the case for the pair of ovaries shown in Figure 5H (i,
ii). Immunohistochemical analysis using an antibody directed against
P450 side chain cleavage enzyme revealed that these structures were not
producing steroids, but were epithelial in origin, as demonstrated by
immunohistochemical staining with an anticytokeratin antibody (data not
shown). These ovarian structures were completely encased within their
ovarian bursas and were attached to apparently normal oviductal and
uterine structures (data not shown). By 7 months of age, the ovaries of Msh4
/
females were virtually
nonexistent, or consisted of massively convoluted tissue structures
(data not shown), with no resemblance to the wild-type ovaries at the
same age. These structures occasionally, but not always, contained a
single or a number of large fluid and blood-filled cysts (see Fig. 5H, below).
Chromosomal pairing in
Msh4
/
oocytes
Analysis of chromosomal pairing in oocytes from Msh4+/+
and Msh4
/
females was performed at
E19 by immunofluorescence because the extremely small amount of tissue
precluded the use of the silver staining technique. However, these analyses
demonstrated clearly that the oocytes from both Msh4+/+ and
Msh4
/
ovaries enter leptonema,
and acquire both their initial synaptonemal complex proteins and at
least one key recombination nodule protein, RAD51 (Fig.
6). As in the males, the number of RAD51 foci on
meiotic chromosomes remained higher in the
Msh4
/
oocytes, compared to
wild-type oocytes (Fig. 6A,B), indicative of a failure to undergo
complete pairing and to enter pachynema (Fig. 6C,D). In those regions
of chromosomes that did undergo pairing, RAD51 foci were lost (Fig.6
C,D, arrows), indicating that the pairing failure itself might be
responsible for the persistence of RAD51 foci. Pairing of homologous
chromosomes appeared to be a more frequent occurrence in Msh4
mutant oocytes than in Msh4 mutant spermatocytes, although the small
amount of tissue available in the embryonic ovaries precluded the possibility
of a more quantitative assessment of pairing in the female germ cells.
|
MSH4 and MSH5 function in the same genetic pathway
The comparison of the meiotic phenotype between
Msh4
/
and
Msh5
/
mice revealed that both
MutS homologs are required in the early stages of meiosis I and are
essential for normal chromosome synapsis during zygonema. In yeast,
genetic analysis has shown that MSH4 and MSH5 function in the same
epistasis group. To investigate whether mammalian MSH4 and MSH5 behave
in a similar manner double mutant
Msh4
/
/Msh5
/
mice were generated. As with the single mutant mice, no adverse phenotype was observed with regard to the viability and survival of
Msh4
/
/Msh5
/
mice and no notable somatic phenotype was apparent. Both male and
female double homozygous mutant mice were infertile. The degree of
chromosomal pairing during meiosis I in spermatocytes was similar to
that seen in Msh5
/
mice, in
that <10% of nuclei contained chromosomes with any degree of pairing, and
no chromosomal condensation was apparent (see Fig. 4E,F; Table 1). The
similarity in meiotic phenotype between Msh5
/
and
Msh4
/
/Msh5
/
mice indicates that mammalian MSH5 functions upstream of MSH4 within
the same epistasis group and both are required at the same time in
meiosis to ensure proper chromosome synapsis.
| |
Discussion |
|---|
|
|
|---|
The generation of mouse lines with inactivating mutations in the genes encoding homologs of the MutS and MutL proteins that function in the MutHLS mismatch repair system has revealed roles for many of these proteins in mitotic mismatch repair and in meiotic recombination. The phenotypes observed in these mutant mouse lines have shown that some of these genes are required for both processes, whereas others are required only for mitotic mismatch repair or only for meiotic recombination. Our results show that MSH4 is essential for male and female meiosis and acts in the same pathway as MSH5.
MSH4 is expressed in meiotic tissues and forms discrete foci on chromosomes during the progression from leptonema to pachynema
In yeast, MSH4 expression is restricted to meiotic cells undergoing
sporulation. Similarly, expression analysis of multiple tissues
revealed that Msh4 mRNA is only detectable in testis and is
absent in all somatic tissues. This result is consistent with that
observed in human tissues and suggests a role for mammalian MSH4 in
meiotic recombination (Paquis-Flucklinger et al. 1997
). Our analysis of
MSH4 expression in meiotic nuclei revealed that it is present at the
various stages of male prophase I. Early in meiosis during the
leptotene stage of prophase I, MSH4 protein accumulated within the
nuclear matrix. Subsequently, in zygonema, MSH4 colocalized with the
synaptonemal complex protein COR1 and was found at multiple sites along
unpaired meiotic chromosomes. The number of these MSH4 foci decreased
until midpachynema to ~47 foci per nucleus, a figure that represents
almost twice the number of estimated recombination sites found in mouse
spermatocytes at diplonema (27 per nucleus; Polani and Jagiello 1976
).
This numerical and temporal correlation between MSH4 foci and chiasmata frequency could indicate a specific functional relationship between the
two phenomena, a suggestion that could be addressed in future studies.
The formation of MSH4 foci on zygotene chromosomes in mice differs from
that seen in yeast where MSH4 only localizes at discrete locations
along synapsed chromosomes during pachynema (Ross-Macdonald and Roeder
1994
). This temporal difference in binding might indicate different
roles of MSH4 during recombination in yeast and mammals.
Meiotic defects in the Msh4
/
male mice
Msh4
/
mutant mice developed
normally and the males showed normal reproductive behavior.
Histological analysis of the testis of
Msh4
/
mutant males indicated
the presence of primary spermatogonia A and B. However, none of the
spermatocytes progressed beyond zygonema because most of the cells that
were present at this stage became apoptotic. The failure of
spermatogonial maturation appears to be related to abnormal chromosome
pairing during the zygotene phase of meiotic prophase I. Analysis of
chromosome spreads revealed that most chromosomes at this stage failed
to undergo pairing, indicative of a role for MSH4 in chromosome
synapsis that is supported by the presence of a large number of MSH4
foci on meiotic chromosomes during zygonema as described above. The
presence of MSH4 foci during pachynema in wild-type mice suggests an
additional role for MSH4 at later stages of meiosis. However, the
analysis of such a later meiotic role was precluded in
Msh4
/
males because of the
induction of apoptosis in the spermatocytes following the failure of
chromosome pairing at zygonema.
The phenotype in yeast is consistent with a role for yeast MSH4 in the
resolution of recombination intermediates. As mentioned above, yeast
MSH4 only localizes on chromosomes at pachynema, and MSH4 null mutant
yeast strains do not show abnormal chromosome synapsis but display a
reduction in crossing over as well as an increase in chromosomal
nondisjunction resulting in reduced spore viability (Ross-Macdonald and
Roeder 1994
). The comparison of the distribution of MSH4 foci along the
meiotic chromosomes at the various stages of prophase I as well as the
phenotypes of MSH4 mutant yeast and mouse strains indicate a functional
difference. Interestingly, the Caenorhabditis elegans gene
him-14, an ortholog of yeast MSH4, is also not required for
pairing or synapsis. Similar to its yeast counterpart, him-14
appears to be required during pachynema and to have a role in crossover
formation (Zalevsky et al. 1999
). This functional difference of MSH4 in
yeast and C. elegans versus mouse may indicate a divergence of
function during evolution.
Ovarian meiosis and development in
Msh4
/
female mice
As in males, meiosis was severely disrupted in Msh4 mutant
females. Analysis of chromosomes in germ cells from embryonic and neonatal ovaries indicated that meiosis I was disrupted in
Msh4
/
females at a similar
stage compared to that of
Msh4
/
males. Although some
chromosome pairing was evident in many Msh4 mutant oocytes,
the majority of chromosomes remained unpaired. The failure of pairing
in these oocytes correlated with an induction of apoptosis, resulting
in the almost complete obliteration of germ cell numbers within the
ovaries of Msh4
/
females by
day 4 pp (Fig. 5). As in the case of
Msh5
/
females, the loss of the
oocyte pool resulted in the disruption of ovarian development and the
complete loss of ovarian structures in the adult
Msh4
/
female. Such ovarian
dysgenesis after germ cell loss is specific to mice lacking MSH5 and
MSH4, as other mutations that result in germ cell depletion do not give
rise to such a severe alteration in ovarian development. For example,
female mice carrying various allelic mutations in the c-kit
ligand Steel factor do not exhibit a loss of ovarian structures,
despite a reduction in oocyte numbers to ~10% of wild type at birth
(Bedell et al. 1995
). Similarly, mice lacking the RecA homolog DMC1
also exhibit a loss of germ cells at birth, but their ovarian
structures remain intact, albeit considerably reduced in size (Pittman
et al. 1998
; Yoshida et al. 1998
). These data clearly indicate that the
progression of meiosis in the embryonic ovary is monitored by a
developmental checkpoint that regulates the survival of meiosis I
oocytes and the subsequent signals that trigger ovarian development and
folliculogenic reorganization.
MSH complexes during meiosis
In yeast the two meiotic MutS homologs MSH4 and MSH5 form
heterodimeric complexes resembling the complexes formed by the mitotic MutS homologs MSH2-MSH3 and MSH2-MSH6 (Marsischky et al. 1996
). It
was also observed that MSH5 deficiency causes a more severe phenotype
than MSH4 deficiency indicating that MSH5 is epistatic to MSH4
(Hollingsworth et al. 1995
). Recently it was reported that mammalian
MSH4 and MSH5 are also capable of forming heterodimeric complexes
(Winand et al. 1998
; Bocker et al. 1999
). The meiotic phenotypes of the
Msh4
/
and
Msh5
/
mice generated by our
laboratory show that both proteins are required for chromosome
synapsis. The comparison of the phenotypes in both mouse lines further
shows that Msh5 inactivation causes a more severe defect in
pairing than Msh4 inactivation. Although only very few of the
nuclei in Msh5
/
spermatocytes
contained chromosomes that underwent homologous or nonhomologous
pairing (10%), the majority of the MSH4 nuclei (69%) contained a
small number of paired chromosomes. In contrast, by the same age 64.9%
of the wild-type spermatocytes were at pachynema with all chromosomes
being fully synapsed. Our results suggest that mammalian MSH4 and MSH5
act within the same genetic pathway and that MSH5 might be epistatic to
MSH4 similar to the situation in yeast. This notion is also supported
by the phenotype of the Msh4
/
/Msh5
/
mice, which is similar to that of the MSH5 mutant mice with almost no
detectable chromosome pairing (in only 10% of the nuclei). It should
be mentioned that in an Msh5 mutant mouse line generated in
another laboratory, chromosome synapsis was also affected but a higher
degree of chromosome pairing was reported (de Vries et al. 1999
). The
difference in the degree of chromosome pairing observed in the two
lines might be caused by differences in the genetic background. Another
possibility is that the two Msh5
/
lines represent
different Msh5 alleles. The
Msh5
/
mouse line generated by
our laboratory carries a null mutation as no Msh5 transcript
or protein is expressed in testis. A direct comparison to the
Msh5 mutant line generated by de Vries et al. (1999)
is difficult to
assess because no RNA or protein data were reported from meiotic tissue.
The role of MMR genes in mammalian meiosis
Msh4 is the last known MutS homolog that has been
inactivated in the mouse germ line, and it is now possible to compare
the biological function of all the known members of the MMR family of
genes. Currently, there is no evidence for a role of three of the five
MutS homologs MSH2, MSH3, and MSH6 in the control of meiosis. As
expected from their germ cell-specific expression pattern and
similarity to their yeast counterparts, mutations in the other two MutS
homologs MSH4 and MSH5 cause a meiotic phenotype. The MSH2-MSH3 and
MSH2-MSH6 complexes function in conjunction with MLH1-PMS2 and
MLH1-MLH3 in mitotic mismatch repair (Wang et al. 1999
; Lipkin et al.
2000
). Although the identity of the proteins that interact with
MSH4-MSH5 during meiotic recombination is not known, it is possible
that MSH4-MSH5 functions in meiosis along with MLH1-PMS2 and/or
MLH1-MLH3. The possibility of such an interaction is supported by the
fact that MLH1 as well as PMS2 have a meiotic function in mouse. The
phenotype in Pms2
/
mutant
males corresponds to Msh4
/
and
Msh5
/
mutant males in that
they show abnormalities in zygonema with incomplete chromosome pairing.
The Pms2
/
phenotype, however,
is less severe in that apoptotic cell death was not reported and
abnormal spermatozoa were produced. In addition, Pms2 mutant
females appear to be able to produce functional oocytes. In contrast,
in both males and females, MLH1 deficiency results in sterility that in
males is caused by apoptotic cell death of the spermatocytes
immediately after pachynema. However, unlike the Msh4,
Msh5, and Pms2 mutants, chromosome synapsis in
Mlh1 mutant males and females is not affected (Baker et al.
1996
; Edelmann et al. 1996
; Woods et al. 1999
). The defect in
Mlh1 mutants appears to be at a later stage in
pachynema/diplonema and the absence of chiasmata in
diplonema suggests that MLH1 is required for the formation and/or
resolution of meiotic crossover sites. At present it is not clear at
what steps MSH4 and MSH5 participate in during meiotic recombination,
nor what structures in the DNA are recognized for binding. It is
possible that both proteins are involved in the early and/or late
events of meiotic recombination. An interesting possibility is that
MSH4-MSH5 may be required for multiple steps of the recombination
process and that at different stages their involvement requires the
interaction with different protein complexes. Many of the proteins that
mediate meiotic recombination have been identified in yeast (for
review, see Roeder 1997
). In mammals several homologs of these genes
have been described and it will be very interesting to determine
whether interactions exist between these homologs and MSH4 or MSH5.
| |
Materials and methods |
|---|
|
|
|---|
Inactivation of Msh4 in embryonic stem cells
A 4.1-kb Sac genomic fragment containing Msh4 exons 4 and
5 derived from a 129Ola
phage library was subcloned into pUC19. Comparison of the mouse and human sequences spanning exons 4 and 5 revealed 90% homology between the two species. A single BglII site was inserted into exon 4 corresponding to human codon 252 by
site-directed mutagenesis. A 2.0-kb BglII fragment containing PGKhygromycin was cloned into exon 4 in the same transcriptional orientation as the Msh4 gene and the resulting targeting
vector was designated pMsh4Ex4. The targeting vector (40 µg) was linearized at the single BamHI side and
electroporated into 2.0 × 107 WW6 ES cells as described
previously (Edelmann et al. 1997
). The ES cells were selected in
hygromycinB (150 µg/ml) and resistant colonies were
isolated after 10 days of selection. Genomic DNA from individual
colonies was subjected to Long Range PCR analysis (Boehringer Mannheim)
and positive ES cell colonies were identified by a 4.3-kb PCR fragment
using forward primer 5'-TGGAAGGATTGGAGCTACGG-3' and reverse
primer 5'-GAAAGCAGCTGCTCCGTATC-3'. The PCR reactions were
performed according to the manufacturer's instructions. For Southern
blot analysis genomic DNA was digested with BglII, transferred to nylon membrane, and hybridized to a genomic probe corresponding to
intron 4 (Fig. 2A).
Generation of Msh4
/
mice
Embryonic stem cells derived from three independently targeted clones were injected into C57Bl/6 blastocysts. All three cell lines gave rise to male chimeric animals that were mated to C57Bl/6 females. Chimeric males derived from all three cell lines transmitted the mutation through their germ line. F1 heterozygous animals were intercrossed to obtain Msh4 homozygous mutant animals.
Northern blot analysis
Mouse multiple tissue Northern blots (Origene) were hybridized with
a full-length human cDNA probe to determine Msh4 expression. For analysis of Msh4 expression in 23-day-old male testis
poly(A) RNA was separated on 1.0% agarose formaldehyde gels and
transferred to nitrocellulose membranes. For hybridization a human cDNA
probe spanning the entire MSH4 coding region and a human
-actin
probe was used.
Histology
For analysis of the first meiotic wave in the testis,
Msh4+/+ and Msh4
/
males were
taken between day 17 pp and day 23pp, corresponding to the end of meiosis I
and meiosis II, respectively. Adult males were used at between 10 and 14 weeks of age. For analysis of female meiosis, embryos were taken
between E16 and E19 and at day 1 through to day 5 pp. Older females
were also used at day 25 pp and adulthood (4 weeks to 7 months of age).
For histological analysis, ovaries and testes were fixed in Bouin's
fixative or 4% buffered formalin for periods of 1 hr until 12 hr,
depending on the size of the specimen. Fixed tissues were processed for
immunohistochemistry by routine methods and the paraffin-embedded
tissues were sectioned at 3-5 µm, depending on the tissue.
Chromosome analysis
Testes were removed from mice between the ages of day 17 pp and day
25 pp, decapsulated and rinsed in
-MEM. Tubules were chopped
coarsely on dental wax and then more finely with watchmaker's forceps.
Large clumps were removed and the supernatant was centrifuged to pellet
the germ cells, which were then resuspended in 20 µl of fresh
-MEM. Aliquots of 4 µl were then applied to a 400-µl bubble of hypotonic (0.5%) saline on parafilm to burst open the cells
and to spread the nuclear contents across the concave surface of the
bubble. Spread nuclei were then picked up on precleaned slides or on to
formvar-coated 200-mesh nickel electron microscopy grids. The nuclei
were then fixed twice in 1% paraformaldehyde (pH 8.2) for 3 min each
on ice, followed by three 1-min washes in 0.4% photoflo-200 (Kodak).
Fixed nuclei were air dried overnight and then used immediately or
stored at
70°C for up to 3 weeks. Nuclei were subjected to
either silver staining in 50% AgNO3 at 55°C for 1 hr, or used
for immunofluorescent analysis of chromosome-associated proteins (see below).
For analysis of female meiotic chromosomes, embryonic ovaries were
removed between E16 and E19 and minced finely in cold
-MEM on
precleaned microscope slides. Cell suspensions were then applied to a
small bubble of hypotonic (0.5%) saline on a clean microscope slide,
stirred gently, and then rested for 3 hr to allow the germ cell nuclei
to sink through the saline and adhere to the slide. Fixation procedures
were the same as for male germ cells. Slides were used for
immunofluorescence as described below.
Immunofluorescence and immunohistochemistry
Slides containing chromosome spreads were subjected to
immunofluorescent staining as previously described (Edelmann et al. 1999
). Primary antibodies used were: (1) a mouse monoclonal antibody against COR1, a component of the mouse SC (1:1000); (2) a rabbit polyclonal antibody directed against the last 12 amino acids of mouse
MSH4 (1:400); and (3) a rabbit polyclonal antibody raised against
mouse RAD51 (1:500).
Paraffin sections were subjected to immunohistochemistry using a rat
hybridoma supernatant against germ cell nuclear antigen-1 (GCNA-1)
(Enders and May 1994
). Alternatively, slides were stained with
hematoxylin and eosin to reveal more detailed histological architecture.
| |
Acknowledgments |
|---|
We thank Peter Moens and Barbara Spyropoulos (University of York, Toronto, Canada) for the gift of anti-COR1 antibody; George Enders (University of Kansas) for the gift of anti-GCNA1 antibody; Veronique Paquis-Flücklinger and Sabine Darmanin for the gift of anti-MSH4 antibodies and helpful discussions. The authors gratefully acknowledge the assistance of Shailesh Shenoy (Department of Anatomy and Structural Biology) with the cooled CCD microscope and various members of the Einstein Analytical Imaging Facility (Frank Macaluso, Leslie Gunther, Carolyn Marks) for their technical support and helpful advice. J.W.P. is a Betty and Sheldon Feinberg Senior Faculty Scholar in Cancer Research. This work was supported by the National Institutes of Health (CA 76329 to W.E., CA 84301 to R.K. and W.E., GM26017 to R.D.K., and Cancer Center grant CA 13330 to AECOM) and a Wyeth-Ayherst grant to J.W.P.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received February 8, 2000; revised version accepted March 22, 2000.
5 These authors contributed equally to this work.
6 Corresponding author.
E-MAIL edelmann{at}aecom.yu.edu; FAX (718) 430-8972.
| |
References |
|---|
|
|
|---|